Gene Therapy Long-Term Follow-Up Should Include Patient Postcards - Cmte.
Executive Summary
Gene therapy clinical trial sponsors should send an annual postcard to all patients beginning five years after the completion of a study as long-term follow-up, FDA's Biological Response Modifiers Advisory Committee recommended Nov. 17.
You may also be interested in...
Gene Therapy Guidance Urges 15-Year Follow-Up, With Five "Close" Years
FDA's draft guidance on gene therapy studies follows the recommendations of the Biological Response Modifiers Advisory Committee in calling for 15 years of follow-up for patients
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011